Rhenman & Partners Asset Management Ab has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.2 Billion distributed in 95 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $49.4M, Unitedhealth Group Inc with a value of $42.5M, Eli Lilly & CO with a value of $42.1M, Regeneron Pharmaceuticals, Inc. with a value of $41M, and Tenet Healthcare Corp with a value of $36.8M.
Examining the 13F form we can see an increase of $188M in the current position value, from $1.01B to 1.2B.
Rhenman & Partners Asset Management Ab is based out at Stockholm, V7
Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.
Portfolio value
$1.2 Billion
Healthcare: $1.2 Billion
Basic Materials: $1.14 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
